The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares



Results

Search articles by EPIC code
ARTICLE

Silence Therapeutics – how’s “transformational deal” partner? Red flags really fluttering?

2019-11-13 15:58:50

Having as recently as June been sub 50p, shares in self-styled “a leader in the discovery, development and delivery of novel RNA therapeutics for the treatment of serious diseases” Silence Therapeutics (SLN) spiked above 100p in July on the back of announcements of a collaboration with, and investment from, Mallinckrodt (NYSE - MNK). The shares have in the last month sparked significantly further – to a current near 400p, giving a more than £300 million market cap. However…

NEWSFLOW NEWSFLOW NEWSFLOW NEWSFLOW NEWSFLOW NEWSFLOW

Search ShareProphets |

Recent Comments |




About ShareProphets

Contact Us

Advertise With Us

Send Us A Tip

Donate


Terms of Service

Privacy Policy

Cookie Policy


Forgot My Password

Forgot My Username

Resend Account Validation Token

Site by Everywhen